iZumi Bio Inc., a South San Francisco-based regenerative medicine company that uses induced pluripotent stem (iPS) cells, has raised $20 million in VC funding since its 2007 inception. Backers include Highland Capital Partners and Kleiner Perkins Caufield & Byers.
The funding amount was disclosed in a USA Today article, about how the company has forged a partnership with Kyoto University‘s Shinya Yamanaka. www.izumibio.com
- PayMate Raises $9 Million
- RazorGator Raises $7.5 Million
- OptiMedica Raises $16 Million
- Codon Devices Raises $20 Million
- Stoke Raises $20 Million